Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

44 - de Sèze M, Petit H, Gallien P, de Sèze MP, Joseph PA, Mazaux JM, et al.
Botulinum A toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-
controlled study in 13 patients with spinal cord disease.
Eur Urol 2002;42:56–62.
45 - Gilles KARSENTY, Jacques CORCOS , Brigitte SCHURCH :
Toxines botuliques : applications urologiques .
Progrès en Urologie (2006), 16, 263-274
46 - P. Gallien - B. Nicolas - S. Petrilli - A. Durufle - E. Chartier-Kastler - A. Ruffion
Traitements pharmacologiques intra-sphinctériens en neuro-urologie
Progrès en Urologie (2007), 17 512-514
47 - Schurch B, Hauri D, Largo M, Kreienbühl B, Meyer E, Rossier AB.
Effets de la toxine botulinique A sur le sphincter strié périurétral des vessies
neurogènes.
J Urol (Paris) 1990;96:375–80.
48 - Brigitte Schurch, Juerg Hodler, Bilijana Rodic :
Botulinum A toxin as a treatment of detrusorsphincter dyssynergia in patients with
spinal cord injury: MRI controlled transperineal injections.
Journal of Neurology,Neurosurgery, and Psychiatry 1997;63:474–476
49 - Dykstra DD, Sidi AA.
Treatement of detrusor-sphincter dyssynergia with botulinum A toxin: a double-
blind study.
Arch Phys Med Rehab 1990;71:24–6.
50 - Gallien P, Reymann J-M, Amarenco G, Nicolas B, de Sèze M, Bellissant E :
Placebo controlled, randomised, double blind study of the effects of botulinum A
toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.
J Neurol Neurosurg Psychiatry 2005;76:1670–1676.
51 - Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al.
The standardisation of terminology of lower urinary tract function: report from the
Standardisation Sub-committee of the International Continence Society.
Neurourol Urodyn 2002;21:167–78
94